We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+24.81%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$18.7B
AUM Growth
+$4.8B
(+35%)
Cap. Flow
+$1.69B
Cap. Flow
% of AUM
9.02%
Top 10 Holdings %
Top 10 Hldgs %
24.14%
Holding
1,702
New
548
Increased
855
Reduced
264
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$140M |
| 2 |
Microsoft
MSFT
|
+$124M |
| 3 |
Apple
AAPL
|
+$117M |
| 4 |
Carrier Global
CARR
|
+$94.7M |
| 5 |
Otis Worldwide
OTIS
|
+$88.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$47.8M |
| 2 |
Abbott
ABT
|
+$25.1M |
| 3 |
Colgate-Palmolive
CL
|
+$24.3M |
| 4 |
Hormel Foods
HRL
|
+$23.2M |
| 5 |
Walmart Inc
WMT
|
+$22.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.9% |
| 2 | Consumer Discretionary | 13.41% |
| 3 | Industrials | 11.79% |
| 4 | Financials | 10.2% |
| 5 | Healthcare | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
CONMED
CNMD
$1.29B
| $300K | ﹤0.01% |
+4,172
| New | +$290K |
|
1227
LGI Homes
LGIH
$1.4B
| $299K | ﹤0.01% |
+3,393
| New | +$238K |
|
1228
Intellia Therapeutics
NTLA
$1.5B
| $298K | ﹤0.01% |
+14,167
| New | +$241K |
|
1229
FTI Consulting
FCN
$4.82B
| $297K | ﹤0.01% |
2,592
-1,096
| -30% | -$133K |
|
1230
Globus Medical
GMED
$10.4B
| $297K | ﹤0.01% |
6,226
-2,435
| -28% | -$117K |
|
1231
Grand Canyon Education
LOPE
$3.71B
| $297K | ﹤0.01% |
+3,285
| New | +$292K |
|
1232
NovaGold Resources
NG
$2.6B
| $297K | ﹤0.01% |
32,303
+18,786
| +139% | +$190K |
|
|
CVET
1233
DELISTED
Covetrus, Inc. Common Stock
CVET
| $297K | ﹤0.01% |
+16,619
| New | +$218K |
|
1234
Adient
ADNT
$1.6B
| $296K | ﹤0.01% |
+18,046
| New | +$274K |
|
1235
Howard Hughes
HHH
$3.93B
| $296K | ﹤0.01% |
5,975
+796
| +15% | +$40.1K |
|
|
MFA
1236
MFA Financial
MFA
$929M
| $296K | ﹤0.01% |
29,762
+16,840
| +130% | +$130K |
|
|
XHR
1237
Xenia Hotels & Resorts
XHR
$1.98B
| $296K | ﹤0.01% |
31,673
+10,330
| +48% | +$96.2K |
|
1238
Wolverine World Wide
WWW
$1.54B
| $295K | ﹤0.01% |
+12,401
| New | +$252K |
|
|
DHC
1239
Diversified Healthcare Trust
DHC
$2.26B
| $294K | ﹤0.01% |
66,460
+16,552
| +33% | +$58.5K |
|
1240
Dynatrace
DT
$12.1B
| $294K | ﹤0.01% |
+7,234
| New | +$238K |
|
|
SKX
1241
DELISTED
Skechers
SKX
| $294K | ﹤0.01% |
+9,357
| New | +$268K |
|
1242
ICU Medical
ICUI
$3.93B
| $293K | ﹤0.01% |
1,592
+530
| +50% | +$105K |
|
|
PFPT
1243
DELISTED
Proofpoint, Inc.
PFPT
| $293K | ﹤0.01% |
2,637
+516
| +24% | +$59K |
|
1244
Aurinia Pharmaceuticals
AUPH
$1.97B
| $292K | ﹤0.01% |
17,998
+3,235
| +22% | +$51.8K |
|
|
PRMW
1245
DELISTED
Primo Water Corporation
PRMW
| $292K | ﹤0.01% |
+21,237
| New | +$238K |
|
|
B
1246
DELISTED
Barnes Group Inc.
B
| $291K | ﹤0.01% |
+7,347
| New | +$282K |
|
1247
Helmerich & Payne
HP
$3.53B
| $290K | ﹤0.01% |
14,859
-56,883
| -79% | -$1.11M |
|
1248
O-I Glass
OI
$1.39B
| $290K | ﹤0.01% |
+32,342
| New | +$250K |
|
|
GAP
1249
The Gap Inc
GAP
$6.84B
| $290K | ﹤0.01% |
22,954
-22,665
| -50% | -$204K |
|
1250
Associated Banc-Corp
ASB
$5.81B
| $289K | ﹤0.01% |
21,148
+5,150
| +32% | +$70K |
|
Similar funds
ProShare Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, ProShare Advisors held 1,702 positions worth $18.7B, up 35% from $13.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
ProShare Advisors deployed $1.69B of net new capital in Q2 2020, opening 548 new positions and adding to 855 existing holdings. Its largest new stake was Carrier Global: 5,097,223 shares worth $113M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Clorox, an estimated $47.8M trimmed.
- ProShare Advisors's largest Q2 2020 buy was Carrier Global: 5,097,223 shares worth $113M.
- ProShare Advisors added most to Amazon in Q2 2020, an estimated $140M increase.
- ProShare Advisors's biggest Q2 2020 reduction was Clorox, cutting an estimated $47.8M.
- ProShare Advisors fully exited Utah Medical Products in Q2 2020, selling an estimated $11.6M.
- ProShare Advisors's ten largest holdings make up 24% of its $18.7B portfolio in Q2 2020.
- ProShare Advisors opened 548 new positions and closed 34 in Q2 2020.
- ProShare Advisors's portfolio value rose 35% quarter-over-quarter to $18.7B.
Based on ProShare Advisors's 13F filing for Q2 2020, filed 3 Aug 2020.